
Sign up to save your podcasts
Or


A new weight loss drug approved by the Food and Drug Administration may make a big impact for those facing obesity. Zepbound (ZEP-bound), includes the same active ingredient as Mounjaro -- a popular weight-loss drug only approved for people with Type 2 diabetes. Dave and Debbie discuss what they know about the drug and how much this new approved medication will cost.
By Debbie Dujanovic and Dave Noriega4.1
4040 ratings
A new weight loss drug approved by the Food and Drug Administration may make a big impact for those facing obesity. Zepbound (ZEP-bound), includes the same active ingredient as Mounjaro -- a popular weight-loss drug only approved for people with Type 2 diabetes. Dave and Debbie discuss what they know about the drug and how much this new approved medication will cost.